Cigarette smoking and progressive brain volume loss in schizophrenia

European Neuropsychopharmacology

Volumn 20, Issue 7, 2010, Pages 454-458

  Van Haren, N E M ^a   Koolschijn, P C M P ^a   Cahn, W ^a   Schnack, H G ^a   Hulshoff Pol, H E ^a   Kahn, R S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Longitudinal; Morphology; MRI; Schizophrenia; Smoking

Indexed keywords

ARTICLE; BRAIN FUNCTION; BRAIN LATERAL VENTRICLE; BRAIN SIZE; CEREBELLUM; CIGARETTE SMOKING; CONTROLLED STUDY; DOSE RESPONSE; EDUCATION; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING;

ANALYSIS OF VARIANCE; BRAIN; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING;

EID: 77953363035     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.02.009     Document Type: Article

References (21)

1. Almeida O.P., Garrido G.J., Lautenschlager N.T., Hulse G.K., Jamrozik K., Flicker L. Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzhemer disease. Am. J. Geriatr. Psychiatry 2008, 16:92-98.
2. Andreasen N.C., Flaum M., Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 1992, 49:615-623.
3. Brody A.L., Mandelkern M.A., Jarvik M.E., Lee G.S., Smith E.C., Huang J.C., Bota R.G., Bartzokis G., London E.D. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol. Psychiatry 2004, 55:77-84.
4. Foll B.L., Goldberg S.R. Effects of nicotine in experimental animals and humans: an update on addictive properties. Handb. Exp. Pharmacol. 2009, 192:335-367.
5. Gallinat J., Meisenzahl E., Jacobsen L.K., Kalus P., Bierbrauer J., Kienast T., Witthaus H., Leopold K., Seifert F., Schubert F., Staedtgen M. Smoking and structural brain deficits: a volumetric MR investigation. Eur. J. NeuroSci. 2006, 24:1744-1750.
6. Hall R.C. Global assessment of functioning. A modified scale. Psychosomatics 1995, 36:267-275.
7. Hulshoff Pol H.E., Kahn R.S. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 2008, 34:354-366.
8. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
9. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: a population-based prevalence study. JAMA 2000, 284:2606-2610.
10. Leonard S., Mexal S., Freedman R. Smoking, genetics and schizophrenia: evidence for self medication. J. Dual. Diagn. 2007, 3:43-59.
11. Pantelis C., Yucel M., Wood S.J., Velakoulis D., Sun D., Berger G., Stuart G.W., Yung A., Phillips L., McGorry P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr. Bull. 2005, 31:672-696.
12. Phelan M., Slade M., Thornicroft G., Dunn G., Holloway F., Wykes T., Strathdee G., Loftus L., McCrone P., Hayward P. The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. Br. J. Psychiatry 1995, 167:589-595.
13. Poirier M.F., Canceil O., Bayle F., Millet B., Bourdel M.C., Moatti C., Olie J.P., Attar-Levy D. Prevalence of smoking in psychiatric patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:529-537.
14. Schnack H.G., Hulshoff Pol H.E., Baare W.F., Staal W.G., Viergever M.A., Kahn R.S. Automated separation of gray and white matter from MR images of the human brain. Neuroimage 2001, 13:230-237.
15. Schnack H.G., Hulshoff H.E., Baare W.F., Viergever M.A., Kahn R.S. Automatic segmentation of the ventricular system from MR images of the human brain. Neuroimage 2001, 14:95-104.
16. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
17. Smitten M.H.t., Smeets R.M.W., Brink W.v.d. Composite Interntional Diagnostic Interview (CIDI). Basis versie 2.1. Lifetime 1998, Psychiatrisch Centrum AMC, Amsterdam.
18. Stephens S.H., Logel J., Barton A., Franks A., Schultz J., Short M., Dickenson J., James B., Fingerlin T.E., Wagner B., Hodgkinson C., Graw S., Ross R.G., Freedman R., Leonard S. Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr. Res. 2009, 109:102-112.
19. Tregellas J.R., Shatti S., Tanabe J.L., Martin L.F., Gibson L., Wylie K., Rojas D.C. Gray matter volume differences and the effects of smoking on gray matter in schizophrenia. Schizophr. Res. 2007, 97:242-249.
20. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Brans R., Carati I., Rais M., Kahn R.S. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol. Psychiatry 2008, 63:106-113.
21. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Mandl R.C., Collins D.L., Evans A.C., Kahn R.S. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology 2007, 32:2057-2066.